We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+13.5%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$46.4B
AUM Growth
+$5.43B
Cap. Flow
+$392M
Cap. Flow %
0.84%
Top 10 Hldgs %
27.02%
Holding
3,987
New
232
Increased
1,371
Reduced
1,431
Closed
185

Sector Composition

Rank Sector Weight
1 Technology 13.46%
2 Financials 8.89%
3 Healthcare 8.8%
4 Industrials 8.29%
5 Consumer Staples 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZEAL
3326
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$7K ﹤0.01%
214
-46
-18% -$1.73K
ISBC
3327
DELISTED
Investors Bancorp, Inc.
ISBC
$7K ﹤0.01%
690
ACNT icon
3328
Ascent Industries
ACNT
$137M
$6K ﹤0.01%
825
-249
-23% -$1.43K
AKBA icon
3329
Akebia Therapeutics
AKBA
$327M
$6K ﹤0.01%
2,000
APLS
3330
DELISTED
Apellis Pharmaceuticals
APLS
$6K ﹤0.01%
107
+77
+257% +$3.26K
ARAY icon
3331
Accuray
ARAY
$28.4M
$6K ﹤0.01%
1,500
-6,375
-81% -$23.4K
DCH
3332
Dauch Corp
DCH
$1.3B
$6K ﹤0.01%
672
-394
-37% -$2.96K
BCML icon
3333
BayCom
BCML
$346M
$6K ﹤0.01%
415
BHK icon
3334
BlackRock Core Bond Trust
BHK
$642M
$6K ﹤0.01%
380
BPT
3335
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$6K ﹤0.01%
2,400
CIO
3336
DELISTED
City Office REIT
CIO
$6K ﹤0.01%
648
+447
+222% +$3.68K
CLDX icon
3337
Celldex Therapeutics
CLDX
$2.77B
$6K ﹤0.01%
+356
New +$6.41K
CLRB icon
3338
Cellectar Biosciences
CLRB
$19.3M
$6K ﹤0.01%
10
DRH icon
3339
Diamondrock Hospitality Co
DRH
$2.63B
$6K ﹤0.01%
681
-427
-39% -$2.86K
ETY icon
3340
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.27B
$6K ﹤0.01%
487
FOR icon
3341
Forestar Group
FOR
$1.44B
$6K ﹤0.01%
279
FPA icon
3342
First Trust Asia Pacific ex-Japan AlphaDEX Fund
FPA
$107M
$6K ﹤0.01%
+190
New +$5.5K
GEO icon
3343
The GEO Group
GEO
$4.13B
$6K ﹤0.01%
639
+220
+53% +$2.11K
GHM icon
3344
Graham Corp
GHM
$1.22B
$6K ﹤0.01%
379
-65
-15% -$955
HCI icon
3345
HCI Group
HCI
$2.28B
$6K ﹤0.01%
112
HEES
3346
DELISTED
H&E Equipment Services
HEES
$6K ﹤0.01%
205
+44
+27% +$1.13K
IAG icon
3347
IAMGOLD
IAG
$8.47B
$6K ﹤0.01%
1,648
IHAK icon
3348
iShares Cybersecurity and Tech ETF
IHAK
$994M
$6K ﹤0.01%
+140
New +$4.89K
IVR icon
3349
Invesco Mortgage Capital
IVR
$776M
$6K ﹤0.01%
172
+67
+64% +$2.08K
JPC icon
3350
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
$6K ﹤0.01%
643

Similar funds

US Bancorp's Q4 2020 Portfolio in Review

As of Q4 2020, US Bancorp held 3,987 positions worth $46.4B, up 13% from $41B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

US Bancorp's Q4 2020 filing shows 232 new, 1,371 increased, 1,431 reduced and 185 closed positions. Its largest new stake was iShares Russell Top 200 Growth ETF: 29,787 shares worth $3.96M. The largest sale was Invesco QQQ Trust, an estimated $104M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • US Bancorp's largest Q4 2020 buy was iShares Russell Top 200 Growth ETF: 29,787 shares worth $3.96M.
  • US Bancorp added most to iShares National Muni Bond ETF in Q4 2020, an estimated $137M increase.
  • US Bancorp's biggest Q4 2020 reduction was Invesco QQQ Trust, cutting an estimated $104M.
  • US Bancorp fully exited iShares iBonds Dec 2020 Term Corporate ETF in Q4 2020, selling an estimated $40.2M.
  • US Bancorp's ten largest holdings make up 27% of its $46.4B portfolio in Q4 2020.
  • US Bancorp opened 232 new positions and closed 185 in Q4 2020.
  • US Bancorp's portfolio value rose 13% quarter-over-quarter to $46.4B.

Based on US Bancorp's 13F filing for Q4 2020, filed 4 Feb 2021.